The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Cannabinoids inhibit N-type calcium channels in neuroblastoma-glioma cells.
Open accessAbstract
The psychoactive properties of Cannabis sativa and its major biologically active constituent, delta 9-tetrahydrocannabinol, have been known for years. The recent identification and cloning of a specific cannabinoid receptor suggest that cannabinoids mimic endogenous compounds affecting neural signals for mood, memory, movement, and pain. Using whole-cell voltage clamp and the cannabinomimetic aminoalkylindole WIN 55,212-2, we have found that cannabinoid receptor activation reduces the amplitude of voltage-gated calcium currents in the neuroblastoma-glioma cell line NG108-15. The inhibition is potent, being half-maximal at less than 10 nM, and reversible. The inactive enantiomer, WIN 55,212-3, does not reduce calcium currents even at 1 microM. Of the several types of calcium currents in NG108-15 cells, cannabinoids predominantly inhibit an omega-conotoxin-sensitive, high-voltage-activated calcium current. Inhibition was blocked by incubation with pertussis toxin but was not altered by prior treatment with hydrolysis-resistant cAMP analogues together with a phosphodiesterase inhibitor, suggesting that the transduction pathway between the cannabinoid receptor and calcium channel involves a pertussis toxin-sensitive GTP-binding protein and is independent of cAMP metabolism. However, the development of inhibition is considerably slower than a pharmacologically similar pathway used by an alpha 2-adrenergic receptor in these cells. Our results suggest that inhibition of N-type calcium channels, which could decrease excitability and neurotransmitter release, may underlie some of the psychoactive effects of cannabinoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamill, O. P., Marty, A., Neher, E., Sakmann, B., & Sigworth, F. J. (1981) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/bf00656997 · Cited by 18,436
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011
The regulation and function of c-fos and other immediate early genes in the nervous system
Sheng, M., & Greenberg, M. E. (1990) · Neuron · doi:10.1016/0896-6273(90)90106-p · Cited by 2,429
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159
Muscarinic activation of ionic currents measured by a new whole-cell recording method.
Horn, R., & Marty, A. (1988) · The Journal of general physiology · doi:10.1085/jgp.92.2.145 · Cited by 1,338
Calcium ions, active zones and synaptic transmitter release
Smith, S. J., & Augustine, G. J. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90199-3 · Cited by 603
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515
Hollister, L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 497
Cannabinoids as Therapeutic Agents
(2019) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429260667 · Cited by 311
Drug receptors and the inhibition of nerve cells
North, R. A. (1989) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1989.tb16855.x · Cited by 309
Brain voltage-sensitive calcium channel subtypes differentiated by omega-conotoxin fraction GVIA.
Reynolds, I. J., Wagner, J. A., Snyder, S. H., Thayer, S. A., Olivera, B. M., & Miller, R. J. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.22.8804 · Cited by 304
Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
Little, P. J., Compton, D. R., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1988) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13256-4 · Cited by 291
Howlett, A. C. (1985) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)12377-8 · Cited by 255
Howlett, A. C., Johnson, M. R., Melvin, L. S., & Milne, G. M. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13196-9 · Cited by 253
Physicochemical Properties, Solubility, and Protein Binding of Δ9 -Tetrahydrocannabinol
Garrett, E. R., & Hunt, C. A. (1974) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600630705 · Cited by 220
Bernheim, L., Beech, D. J., & Hille, B. (1991) · Neuron · doi:10.1016/0896-6273(91)90226-p · Cited by 219
Self-citationCannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain
Bidaut‐Russell, M., Devane, W. A., & Howlett, A. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08815.x · Cited by 208
The central neuropharmcology of psychotropic cannabinoids
Pertwee, R. G. (1988) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(88)90106-4 · Cited by 178
The physiological role of calcium-dependent channels
Marty, A. (1989) · Trends in Neurosciences · doi:10.1016/0166-2236(89)90090-8 · Cited by 161
Hollister, L. E. (1986) · PubMed · Cited by 130
Docherty, R. J. (1988) · The Journal of Physiology · doi:10.1113/jphysiol.1988.sp017027 · Cited by 129
Aminoalkylindoles: actions on specific G-protein-linked receptors.
Pacheco, M., Childers, S. R., Arnold, R. A., Casiano, F. M., & Ward, S. J. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24755-3 · Cited by 124
Neuronal localization of cannabinoid receptors and second messengers in mutant mouse cerebellum
Herkenham, M. A., Groen, B. G. S., Lynn, A. B., Costa, B., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90096-e · Cited by 111
Nye, J. S., Seltzman, H. H., Pitt, C. G., & Snyder, S. H. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23705-3 · Cited by 54
Membrane responses to norepinephrine in cultured brown fat cells.
Lucero, M. T., & Pappone, P. A. (1990) · The Journal of General Physiology · doi:10.1085/jgp.95.3.523 · Cited by 50
McFadzean, I., & Docherty, R. J. (1989) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1989.tb00781.x · Cited by 46
Roth, S. H. (1978) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y78-154 · Cited by 44
Cited by
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819
Self-citationThe Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077
“Cannabinoids can also inhibit different types of calcium channels (Mackie and Hille, 1992; Gebremedhin et al., 1999) and activate certain PACHER et al. Page 5 Pharmacol Rev. Author manuscript; available in PMC 2008 February 13.”
BackgroundThe molecular logic of endocannabinoid signalling
Piomelli, D. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1247 · Cited by 1,957
Galiègue, S., Mary, S., Marchand, J., Dussossoy, D., Carrière, D., Carayon, P., Bouaboula, M., Shire, D., LE Fur, G., & Casellas, P. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20780.x · Cited by 1,749
Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses
Wilson, R. I., & Nicoll, R. A. (2001) · Nature · doi:10.1038/35069076 · Cited by 1,607
“jpg" NDATA ITEM> ]> Marijuana affects brain function primarily by activating the G-protein-coupled cannabinoid receptor-1 (CB1”
Metadata
- Authors
- Mackie, K., & Hille, B.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-05
- Volume
- 89
- Issue
- 9
- Pages
- 3825-3829
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2018953051
- Cited by
- 694
- References
- 27
- FWCI
- 11.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.